Kindred Healthcare, Inc. (KND) Upgraded at Zacks Investment Research

Zacks Investment Research upgraded shares of Kindred Healthcare, Inc. (NYSE:KND) from a sell rating to a hold rating in a research note issued to investors on Tuesday morning.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

A number of other research firms have also commented on KND. BidaskClub lowered shares of Kindred Healthcare from a hold rating to a sell rating in a research report on Monday, July 31st. Deutsche Bank AG cut their target price on shares of Kindred Healthcare from $13.00 to $10.00 and set a buy rating for the company in a research report on Monday, August 7th. Royal Bank Of Canada reiterated a sector perform rating and issued a $8.50 target price (up from $7.50) on shares of Kindred Healthcare in a research report on Thursday, November 9th. ValuEngine upgraded shares of Kindred Healthcare from a sell rating to a hold rating in a research report on Thursday, November 9th. Finally, Stifel Nicolaus upgraded shares of Kindred Healthcare from a sell rating to a hold rating and set a $7.00 target price for the company in a research report on Monday. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the stock. The stock presently has an average rating of Hold and a consensus price target of $8.86.

Shares of Kindred Healthcare (NYSE KND) traded up $0.40 during mid-day trading on Tuesday, reaching $8.20. 841,700 shares of the company’s stock were exchanged, compared to its average volume of 1,198,287. The company has a market cap of $712.85, a PE ratio of 41.00 and a beta of 1.12. The company has a debt-to-equity ratio of 6.22, a current ratio of 1.55 and a quick ratio of 1.53. Kindred Healthcare has a 1-year low of $5.50 and a 1-year high of $11.90.

Kindred Healthcare (NYSE:KND) last released its quarterly earnings results on Monday, November 6th. The health services provider reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.08. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.44 billion. Kindred Healthcare had a negative net margin of 8.06% and a positive return on equity of 2.29%. The business’s revenue for the quarter was down 5.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.05 EPS. analysts forecast that Kindred Healthcare will post 0.27 EPS for the current fiscal year.

WARNING: “Kindred Healthcare, Inc. (KND) Upgraded at Zacks Investment Research” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://sportsperspectives.com/2017/11/24/kindred-healthcare-inc-knd-upgraded-at-zacks-investment-research.html.

Large investors have recently modified their holdings of the company. BlackRock Inc. raised its stake in Kindred Healthcare by 0.3% in the second quarter. BlackRock Inc. now owns 10,808,864 shares of the health services provider’s stock worth $125,923,000 after buying an additional 29,673 shares in the last quarter. Vanguard Group Inc. raised its stake in Kindred Healthcare by 8.6% in the second quarter. Vanguard Group Inc. now owns 8,031,919 shares of the health services provider’s stock worth $93,572,000 after buying an additional 635,000 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Kindred Healthcare by 5.6% in the second quarter. Dimensional Fund Advisors LP now owns 6,004,440 shares of the health services provider’s stock worth $69,952,000 after buying an additional 315,752 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Kindred Healthcare by 69.8% in the third quarter. JPMorgan Chase & Co. now owns 3,572,684 shares of the health services provider’s stock worth $24,830,000 after buying an additional 1,468,066 shares in the last quarter. Finally, Glenview Capital Management LLC increased its stake in shares of Kindred Healthcare by 18.8% during the second quarter. Glenview Capital Management LLC now owns 2,374,713 shares of the health services provider’s stock valued at $27,665,000 after purchasing an additional 375,000 shares in the last quarter. 88.62% of the stock is owned by hedge funds and other institutional investors.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply